YTHDF2 is detected to be downregulated in colorectal cancer (CRC), and it has been found to mediate the degradation of X inactivate-specific transcript (XIST), a long non-coding RNA, which may contribute to accelerated tumor growth and metastasis in CRC [89]. Here, XIST is linked to colorectal carcinoma.